, Collaborative Group on Hormonal Factors in Breast C. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies, Lancet, vol.347, pp.1713-1740, 1996.

A. C. Antoniou, A. P. Cunningham, and J. Peto, The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions, Br J Cancer, vol.98, pp.1457-66, 2008.

D. Gadzicki, D. G. Evans, and H. Harris, Genetic testing for familial/hereditary breast cancercomparison of guidelines and recommendations from the UK, France, The Netherlands and Germany, J Community Genet, vol.2, pp.53-69, 2011.

E. R. Thompson, S. M. Rowley, and N. Li, Panel testing for familial breast cancer: calibrating the tension between research and clinical care, J Clin Oncol, vol.34, pp.1455-1464, 2016.

M. C. Southey, Z. L. Teo, and J. G. Dowty, A PALB2 mutation associated with high risk of breast cancer, Breast Cancer Res, vol.12, p.109, 2010.

N. Rahman, S. Seal, and D. Thompson, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene, Nat Genet, vol.39, pp.165-172, 2007.

S. Casadei, B. M. Norquist, and T. Walsh, Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer, Cancer Res, vol.71, pp.2222-2231, 2011.

A. C. Antoniou, S. Casadei, and T. Heikkinen, Breast-cancer risk in families with mutations in PALB2, N Engl J Med, vol.371, pp.497-506, 2014.

S. V. Tavtigian, P. J. Oefner, and D. Babikyan, Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer, Am J Hum Genet, vol.85, pp.427-473, 2009.

A. Renwick, D. Thompson, and S. Seal, ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles, Nat Genet, vol.38, pp.873-878, 2006.

L. Calvez-kelm, F. Lesueur, F. Damiola, and F. , Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study, Breast Cancer Res, vol.13, p.6, 2011.

A. Meindl, H. Hellebrand, and C. Wiek, Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene, Nat Genet, vol.42, pp.410-414, 2010.

L. Golmard, L. Castera, and S. Krieger, Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers, Eur J Hum Genet, vol.25, pp.1345-53, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02194429

D. J. Park, F. Lesueur, and T. Nguyen-dumont, Rare mutations in XRCC2 increase the risk of breast cancer, Am J Hum Genet, vol.90, pp.734-743, 2012.

D. J. Park, K. Tao, L. Calvez-kelm, and F. , Rare mutations in RINT1 predispose carriers to breast and lynch syndrome-spectrum cancers, Cancer Discov, vol.4, pp.804-819, 2014.

F. Damiola, M. Pertesi, and J. Oliver, Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study, Breast Cancer Res, vol.16, p.58, 2014.

F. S. Hilbers, J. T. Wijnen, and N. Hoogerbrugge, Rare variants in XRCC2 as breast cancer susceptibility alleles, J Med Genet, vol.49, pp.618-638, 2012.

N. Li, E. R. Thompson, and S. M. Rowley, Reevaluation of RINT1 as a breast cancer predisposition gene, Breast Cancer Res Treat, vol.159, pp.385-92, 2016.

D. F. Easton, P. D. Pharoah, and A. C. Antoniou, Genepanel sequencing and the prediction of breast-cancer risk, N Engl J Med, vol.372, pp.2243-57, 2015.

S. Ognjanovic, M. Olivier, and T. L. Bergemann, Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database, Cancer, vol.118, pp.1387-96, 2012.

S. V. Tavtigian and G. Chenevix-trench, Growing recognition of the role for rare missense substitutions in breast cancer susceptibility, Biomark Med, vol.8, pp.589-603, 2014.

O. M. Sinilnikova, M. G. Dondon, and S. Eon-marchais, GENESIS: a French national resource to study the missing heritability of breast cancer, BMC Cancer, vol.16, p.13, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01662200

J. Grimberg, S. Nawoschik, and L. Belluscio, A simple and efficient non-organic procedure for the isolation of genomic DNA from blood, Nucleic Acids Res, vol.17, p.8390, 1989.

H. Li and R. Durbin, Fast and accurate long-read alignment with burrows-wheeler transform, Bioinformatics, vol.26, pp.589-95, 2010.

E. G. Garrison, Haplotype-based variant detection from short-read sequencing. ar Xiv. preprint, ArXiv, vol.1207, p.3907, 2012.

A. Mckenna, M. Hanna, and E. Banks, The genome analysis toolkit: a map reduce framework for analyzing next-generation DNA sequencing data, Genome Res, vol.20, pp.1297-303, 2010.

J. T. Robinson, H. Thorvaldsdottir, and W. Winckler, Integrative genomics viewer, Nat Biotechnol, vol.29, pp.24-30, 2011.

H. Thorvaldsdottir, J. T. Robinson, and J. P. Mesirov, Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration, Brief Bioinform, vol.14, pp.178-92, 2013.

K. S. Pollard, M. J. Hubisz, and K. R. Rosenbloom, Detection of nonneutral substitution rates on mammalian phylogenies, Genome Res, vol.20, pp.110-131, 2010.

P. C. Ng and S. Henikoff, Predicting deleterious amino acid substitutions, Genome Res, vol.11, pp.863-74, 2001.

I. Adzhubei and D. M. Jordan, Sunyaev SR. predicting functional effect of human missense mutations using poly Phen-2, Curr Protoc Hum Genet. Chapter, vol.7, p.20, 2013.

M. Kircher, D. M. Witten, and P. Jain, A general framework for estimating the relative pathogenicity of human genetic variants, Nat Genet, vol.46, pp.310-315, 2014.

S. V. Tavtigian, G. B. Byrnes, and D. E. Goldgar, Classification of rare missense substitutions, using risk surfaces, with genetic-and molecularepidemiology applications, Hum Mutat, vol.29, pp.1342-54, 2008.

K. Tomoshige, K. Matsumoto, and T. Tsuchiya, Germline mutations causing familial lung cancer, J Hum Genet, vol.60, pp.597-603, 2015.

D. R. Robinson, S. Kalyana-sundaram, and Y. M. Wu, Functionally recurrent rearrangements of the MAST kinase and notch gene families in breast cancer, Nat Med, vol.17, pp.1646-51, 2011.

A. Gratchev, P. Strein, and J. Utikal, Molecular genetics of Xeroderma pigmentosum variant, Exp Dermatol, vol.12, pp.529-565, 2003.

D. Palma, A. Morren, M. A. Ged, and C. , Diagnosis of Xeroderma pigmentosum variant in a young patient with two novel mutations in the POLH gene, Am J Med Genet A, vol.173, pp.2511-2517, 2017.

N. Jalkh, E. Chouery, and Z. Haidar, Nextgeneration sequencing in familial breast cancer patients from Lebanon, BMC Med Genomics, vol.10, p.8, 2017.

C. Speckmann, S. S. Sahoo, and M. Rizzi, Clinical and molecular heterogeneity of RTEL1 deficiency, Front Immunol, vol.8, p.449, 2017.

C. Kannengiesser, R. Borie, and C. Menard, Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis, Eur Respir J, vol.46, pp.474-85, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01214563

J. D. Cogan, J. A. Kropski, and M. Zhao, Rare variants in RTEL1 are associated with familial interstitial pneumonia, Am J Respir Crit Care Med, vol.191, pp.646-55, 2015.

B. D. Stuart, J. Choi, and S. Zaidi, Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening, Nat Genet, vol.47, pp.512-519, 2015.

S. R. Cardoso, A. Ellison, and A. J. Walne, Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies, Haematologica, vol.102, pp.293-299, 2017.

L. Calvez-kelm, F. Lesueur, F. Damiola, and F. , Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry (CFR) case-control mutation screening study, Breast Cancer Res, vol.13, p.6, 2011.

M. Tischkowitz, M. Capanu, and N. Sabbaghian, Rare germline mutations in PALB2 and breast cancer risk: a population-based study, Hum Mutat, vol.33, pp.674-80, 2012.

Z. L. Teo, D. J. Park, and E. Provenzano, Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families, Breast Cancer Res, vol.15, p.17, 2013.

J. L. Bernstein, S. Teraoka, and M. C. Southey, Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c. 1066-6T>G (IVS10-6T>G) from the breast cancer family registry, Hum Mutat, vol.27, pp.1122-1130, 2006.

D. E. Goldgar, S. Healey, and J. G. Dowty, Rare variants in the ATM gene and risk of breast cancer, Breast Cancer Res: BCR, vol.13, p.73, 2011.

M. C. Southey, D. E. Goldgar, and R. Winqvist, CHEK2 and ATM rare variants and cancer risk: data from COGS, J Med Genet, vol.53, pp.800-811, 2016.

G. R. Abecasis, S. S. Cherny, and W. O. Cookson, Merlin--rapid analysis of dense genetic maps using sparse gene flow trees, Nat Genet, vol.30, pp.97-101, 2002.

J. Y. Park, T. R. Singh, and N. Nassar, Breast cancerassociated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair, Oncogene, vol.33, pp.4803-4815, 2014.

I. Catucci, P. Radice, and R. L. Milne, The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk, Breast Cancer Res, vol.18, p.111, 2016.

H. Hellebrand, C. Sutter, and E. Honisch, Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer, Hum Mutat, vol.32, pp.2176-88, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00616697

M. J. Landrum, J. M. Lee, and G. R. Riley, ClinVar: public archive of relationships among sequence variation and human phenotype, Nucleic Acids Res, vol.42, pp.980-985, 2014.

S. M. Harrison, E. R. Riggs, and D. R. Maglott, Using ClinVar as a resource to support variant interpretation, Curr Protoc Hum Genet, vol.89, pp.8-16, 2016.